Cytek Biosciences Inc. (CTKB)
5.78
-0.10 (-1.70%)
At close: Jan 22, 2025, 3:59 PM
5.77
-0.09%
After-hours Jan 22, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -101.56 | 533.13 | 494.18 | 128.53 | -148.27 |
| PS Ratio | 6.39 | 8.37 | 17.06 | 26.87 | 43.10 |
| PB Ratio | 3.14 | 3.23 | 5.37 | -155.66 | -59.83 |
| P/FCF Ratio | 2.72K | -62.15 | 8.21K | 183.33 | -169.49 |
| P/OCF Ratio | 233.63 | -112.28 | 471.45 | 164.62 | -181.49 |
| OCF/S Ratio | 0.03 | -0.07 | 0.04 | 0.16 | -0.24 |
| Debt / Equity Ratio | 0.04 | 0.04 | n/a | -0.17 | n/a |
| Quick Ratio | 5.89 | 8.28 | 12.43 | 6.99 | 2.34 |
| Current Ratio | 6.97 | 9.26 | 13.43 | 7.86 | 3.22 |
| Asset Turnover | 0.39 | 0.32 | 0.28 | 0.42 | 0.82 |
| Interest Coverage | -13.45 | -0.71 | 3.70 | 41.02 | 3.73K |
| Return on Equity (ROE) | -0.03 | 0.01 | 0.01 | -1.21 | 0.40 |
| Return on Assets (ROA) | -0.02 | 0.00 | 0.01 | 0.09 | -0.24 |
| Return on Capital (ROIC) | -0.06 | -0.00 | 0.01 | 0.07 | 0.08 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 56.69% | 61.56% | 61.86% | 55.70% | 49.54% |
| Net Profit Margin | -6.29% | 1.57% | 3.45% | 20.91% | -29.07% |
| Pretax Profit Margin | -8.14% | 0.77% | 4.65% | 15.54% | -28.15% |
| Operating Profit Margin | -14.43% | -1.11% | 5.04% | 14.71% | 6.44% |
| FCF Margin | 0.24% | -13.47% | 0.21% | 14.66% | -25.43% |
| EBITDA Margin | -2.28% | 5.81% | 8.13% | 16.55% | -27.61% |